Objective To evaluate the effect of anticoagulant therapy in the patients with non-small cell
lung cancer (NSCLC). Methods One hundred and fifty-nine patients with NSCLC without …

The purpose of this study was to establish the safety and efficacy of sodium warfarin in the
secondary prophylaxis of venous thrombosis in patients with cancer. This was an inception …

Malignite, derin ven trombozu için önemli bir risk faktörüdür. Prostat, pankreas ve akci¤ er
kanserleri s› kl› kla trombozlarla birlikte görülmektedir. Venöz tromboembolizm kanserli …

The association of cancer and thrombotic events was first described by Trousseau in 1865.
The spectrum of these episodes vary in severity, and these can present during or even prior …

Venous thromboembolism (VTE) is a common complication in patients with cancer. Previous
randomized studies have demonstrated that the rates of recurrent VTE are lower in patients …

Introduction La survenue de maladie veineuse thromboembolique (MVTE) est fréquente en
cas de cancer bronchopulmonaire (CBP) et est considérée comme la deuxième cause de …

Venous thromboembolism is a common complication of malignancy. Lung cancer is
considered one of the most thrombogenic cancer types. Primary thromboprophylaxis is not …

Introduction Le cancer broncho-pulmonaire (CBP) est l'un des cancers les plus pourvoyeurs
de maladies veineuses thromboemboliques (MVTE). L'objectif de ce travail était d'étudier les …

Background: Patients with cancer, including lung cancer are at an increased risk for venous
thromboembolism and frequently are anticoagulated. Due to concerns of bleeding and drug …

Venous thromboembolic disease (VTED), defined by the occurrence of a deep thrombosis
and/or lung embolism. It is a frequent complication of cancer, particularly during …